Malaria News and Research

Latest Malaria News and Research

HP partners with nonprofit to help detect malaria outbreaks, improve health monitoring in Botswana

Hewlett-Packard on Monday announced it will provide "smartphones and cloud computing technology to nonprofit group Positive Innovation for the Next Generation (PING)" to help improve health monitoring and malaria detection in Botswana, Venture Beat reports.

8 Jun 2011

International coalition launches common platform to end AIDS epidemic

An international coalition of scientists and activists today launched a common platform for ending the AIDS epidemic. Thirty years into the epidemic, as world leaders come together at the United Nations to recommit to a global AIDS response, the broad-based international coalition issued a statement calling for world leaders to support a rational, evidence-based approach to responding to AIDS.

8 Jun 2011

MMV honors UT Southwestern with Project of the Year for new anti-malarial drug discovery

The discovery of a potential new anti-malarial drug by a UT Southwestern Medical Center-led research team has been awarded Project of the Year by Medicines for Malaria Venture.

7 Jun 2011

Crucell, GSK and PATH MVI partner to develop second-generation vaccine against malaria

The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline.

7 Jun 2011

Former Malian health minister indicted in case about misuse of global fund donations

Oumar Ibrahim Toure, a former Malian health minister, "has been indicted for his role over the misuse of donor funds to fight malaria and tuberculosis in the poor West African nation, Mali's supreme court said in a statement" on Thursday, Reuters reports.

7 Jun 2011

PATH malaria vaccine initiative to collaborate with GSK and Crucell in development of 2nd-generation malaria vaccine

The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.

6 Jun 2011

PING, HP partner to reduce malaria through mobile health monitoring technology

On the heels of the United Nations Social Innovation Summit, HP and nonprofit organization Positive Innovation for the Next Generation (PING) are launching a collaboration to improve the quality and efficiency of disease surveillance in Botswana through mobile health monitoring technology that can enhance protection and prevention against major malaria outbreaks.

6 Jun 2011

International drug policy panel calls for legalization of some drugs, de-criminalizing drug use

The Global Commission on Drug Policy - a panel that includes former U.N. Secretary-General Kofi Annan, Global Fund to Fight AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine, and several other current and former world leaders - has released a report calling for "the legalization of some types of drugs and an end to the criminalization of drug users," The Voice of Russia reports.

4 Jun 2011

Political engagement with China influences involvement in health

After discussing the Global Fund to Fight AIDS, Tuberculosis and Malaria's decision to freeze grant payments to China, Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations, writes on the council's "Asia Unbound" blog, "In order to encourage the participation of China's civil society groups in global health, it is important to allay the fears of Chinese leaders.

4 Jun 2011

Climate change can harm indigenous peoples' health

The Canadian Arctic. The Amazonian jungle. The fringes of an African rainforest. These lands are home to some of the most isolated and vulnerable people in the world - the indigenous populations of Canada, Peru and Uganda. Because of their dependence on the land for food and water, indigenous peoples' health is particularly affected by climatic changes. Indeed, they are already seeing dramatic effects due to changing temperatures.

3 Jun 2011

Opinion: Integrate NTD, HIV, TB and malaria programs

In a New England Journal of Medicine opinion piece, Peter Hotez of the Sabin Vaccine Institute and colleagues, including Jeffrey Sachs of the Earth Institute of Columbia University, outline how integrating treatment of neglected tropical diseases (NTD) into HIV/AIDS, tuberculosis and malaria control efforts could speed up progress toward attaining the sixth Millennium Development Goal.

3 Jun 2011

New Kaiser Family Foundation tool shows which global health interventions are working

Today, the Kaiser Family Foundation unveiled an innovative, online tool that allows users to learn quickly and easily about which global health interventions work. The Global Health Intervention Review (GHIR) compiles the latest information on the efficacy of key global health interventions, including the strength of the evidence, and presents the information in a variety of accessible formats. Users can view a comprehensive overview and a key findings table.

2 Jun 2011

New study identifies odor molecules that disrupt CO2-sensing machinery of mosquitoes

Female blood-feeding mosquitoes, some species of which can transmit deadly diseases such as malaria and dengue to humans, largely find their human blood meals by detecting carbon dioxide emitted when people exhale.

2 Jun 2011

Media examine funding for HIV/AIDS as disease turns 30

"As the war on AIDS heads into its fourth decade, the need for funds is spiralling relentlessly higher, prompting a quest for new resources from consumer levies to contributions from developing giants," Agence France-Presse/France 24 reports (5/30).

1 Jun 2011

Scientists find increases in rain and temperature could signal deadly cholera outbreaks months before they strike

With recent deadly cholera outbreaks in Haiti and Cameroon providing the latest indication of a menacingly resurgent disease, scientists have discovered rain and temperature fluctuations in at-risk areas could predict epidemics months in advance, according to a new study published today in the June 2011 issue of the American Journal of Tropical Medicine and Hygiene.

1 Jun 2011

AIDS epidemic turns 30

It is 30 years since the beginning of the AIDS epidemic. It was fatal then but has now become a treatable, if still incurable, chronic illness. AIDS therapy now has tools that prolong the lives of people infected with the virus and prevent others from acquiring it. They range from antiretroviral therapy (ART), to circumcision and campaigns to reduce promiscuity. On the horizon are gels and pills that protect against infection during intercourse. Even the outlook for an AIDS vaccine is no longer as bleak as it used to be.

31 May 2011

Scientists study key malaria protein structure to demonstrate how cells grow and move

Researchers from the Walter and Eliza Hall Institute have overturned conventional wisdom on how cell movement across all species is controlled, solving the structure of a protein that cuts power to the cell 'motor'. The protein could be a potential drug target for future malaria and anti-cancer treatments.

31 May 2011

Novartis employees to do volunteer work for non-profit groups during 15th annual Community Partnership Day

Some 200 employees of Novartis Pharmaceuticals Canada Inc. will again this year be helping out with cleaning, painting and various other chores and activities at 15 Montreal-area organizations as part of their 15th annual Community Partnership Day, during which they leave their offices for the day to do volunteer work for non-profit groups. It is part of a global effort by Novartis employees that involves 20,000 employees in 55 countries.

30 May 2011

The Economist examines lack of attention to Plasmodium vivax malaria parasite

The Economist profiles Plasmodium vivax, a type of malaria that affects between 80 million to 390 million people worldwide annually with a cost to sufferers between $1.4 billion and $4 billion each year.

27 May 2011

Nature special issue focuses on vaccines

The May 26 issue of Nature explores vaccines, which the journal says "are responsible for some of the world's greatest public health triumphs." Though new vaccines for deadly diseases have been developed in the past 10 years, and more are in development, "funding is tight, and unfounded doubts about the safety of vaccines persist." The issue features stories on polio, measles, HIV/AIDS, tuberculosis and malaria, as well as issues surrounding vaccine rejection and hysteria about risk.

27 May 2011

Malaria News and Research

Latest Malaria News and Research

HP partners with nonprofit to help detect malaria outbreaks, improve health monitoring in Botswana

International coalition launches common platform to end AIDS epidemic

MMV honors UT Southwestern with Project of the Year for new anti-malarial drug discovery

Crucell, GSK and PATH MVI partner to develop second-generation vaccine against malaria

Former Malian health minister indicted in case about misuse of global fund donations

PATH malaria vaccine initiative to collaborate with GSK and Crucell in development of 2nd-generation malaria vaccine

PING, HP partner to reduce malaria through mobile health monitoring technology

International drug policy panel calls for legalization of some drugs, de-criminalizing drug use

Political engagement with China influences involvement in health

Climate change can harm indigenous peoples' health

Opinion: Integrate NTD, HIV, TB and malaria programs

New Kaiser Family Foundation tool shows which global health interventions are working

New study identifies odor molecules that disrupt CO2-sensing machinery of mosquitoes

Media examine funding for HIV/AIDS as disease turns 30

Scientists find increases in rain and temperature could signal deadly cholera outbreaks months before they strike

AIDS epidemic turns 30

Scientists study key malaria protein structure to demonstrate how cells grow and move

Novartis employees to do volunteer work for non-profit groups during 15th annual Community Partnership Day

The Economist examines lack of attention to Plasmodium vivax malaria parasite

Nature special issue focuses on vaccines

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Malaria News and Research

Latest Malaria News and Research

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in